adenosine has been researched along with Nerve Degeneration in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (17.86) | 18.7374 |
1990's | 6 (21.43) | 18.2507 |
2000's | 13 (46.43) | 29.6817 |
2010's | 3 (10.71) | 24.3611 |
2020's | 1 (3.57) | 2.80 |
Authors | Studies |
---|---|
Cheng, X; Huang, X; Li, X; Shu, L | 1 |
Górska, A; Gołembiowska, K; Noworyta-Sokołowska, K | 1 |
Amori, L; Guidetti, P; Marinozzi, M; Pellicciari, R; Schwarcz, R; Wu, HQ | 1 |
Milbrandt, J; Press, C | 1 |
Bell, MJ; Cheng, D; Dubey, RK; Gillespie, DG; Haselkorn, ML; Homanics, GE; Jackson, EK; Janesko-Feldman, K; Jenkins, LW; Kochanek, PM; Schnermann, J; Shellington, DK; Vagni, VA | 1 |
Amorim, RP; de Oliveira, DM; Fernandes, MJ; Nehlig, A; Persike, DS; Rosim, FE | 1 |
Fowler, JC; Gervitz, LM; Nalbant, D; Williams, SC | 1 |
Othman, T; Rivkees, SA; Schwartz, M; Turner, CP; Yan, H | 1 |
Dalpiaz, A; Manfredini, S | 1 |
Casali, EA; Lara, DR; Leke, R; Oses, JP; Portela, LV; Sarkis, JJ; Schmidt, AP; Souza, DO; Wofchuk, S | 1 |
Bardenheuer, HJ; Kiessling, M; Martin, E; Matejic, D; Plaschke, K; Schroeck, H; Sommer, C; Weigand, MA | 1 |
Baier-Bitterlich, G; Böck, G; Heftberger, V; Podhraski, V; Tomaselli, B | 1 |
Cheng, JT; Lai, DM; Liu, IM; Tu, YK | 1 |
Ribeiro, JA | 1 |
Kawai, A; Monden, M; Shintani, M; Shiomi, H; Tamura, Y | 1 |
Chen, JF; de Mendonça, A; Domenici, MR; Geiger, J; Lopes, LV; Melani, A; Pedata, F; Popoli, P; Sonsalla, PK | 1 |
Geiger, JD; LaBella, FS; Nagy, JI | 1 |
Baranowski, K; Ingoglia, NA; Pilchman, J; Sharma, SC; Sturman, JA | 1 |
Beenhakker, M; Carter, MF; Jacobson, KA; Lin, RC; von Lubitz, DK | 1 |
Hsu, SS; Malouf, AT; Newell, DW; Tucker, A; Winn, HR | 1 |
Dora, CD; Koch, S; Liu, S; Ruenes, G; Sanchez, A; Yezierski, RP | 1 |
Evans, PJ; Hare, GM; Hunter, DA; MacKinnon, SE; Midha, R; Nakao, Y; Wade, JA | 1 |
Kitamura, Y; Matsuoka, Y; Ohta, S; Okazaki, M; Sekino, Y; Takata, K; Taniguchi, T | 1 |
Araki, T; Imai, Y; Itoyama, Y; Kato, H; Mizugaki, M; Tanji, H | 1 |
Martinez-Mir, MI; Palacios, JM; Probst, A | 1 |
Di Patre, PL; Giovannini, MG; Pazzagli, M; Pedata, F; Pepeu, G | 1 |
Connick, JH; Stone, TW | 1 |
Ross, SM; Sabri, MI; Spencer, PS | 1 |
5 review(s) available for adenosine and Nerve Degeneration
Article | Year |
---|---|
Emerging Roles of N6-Methyladenosine Modification in Neurodevelopment and Neurodegeneration.
Topics: Adenosine; Animals; Humans; Nerve Degeneration; Nervous System; Nervous System Diseases; Neurogenesis; Synapses | 2021 |
Adenosine A(1) receptor: analysis of the potential therapeutic effects obtained by its activation in the central nervous system.
Topics: Adenosine; Animals; Biotransformation; Central Nervous System; Humans; Nerve Degeneration; Neuroprotective Agents; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Structure-Activity Relationship | 2002 |
What can adenosine neuromodulation do for neuroprotection?
Topics: Adenosine; Animals; Brain Damage, Chronic; Brain-Derived Neurotrophic Factor; Cell Survival; Glutamic Acid; Humans; Hypoxia; Nerve Degeneration; Neurons; Neuroprotective Agents; Reactive Oxygen Species; Receptors, Purinergic P1 | 2005 |
Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation.
Topics: Adenosine; Animals; Brain; Brain Diseases; Brain Injury, Chronic; Cell Survival; Cytoprotection; Humans; Nerve Degeneration; Neuroprotective Agents; Receptor, Adenosine A2A | 2007 |
Adenosine: a prototherapeutic concept in neurodegeneration.
Topics: Adenosine; Animals; Brain; Brain Diseases; Glutamic Acid; Humans; Nerve Degeneration; Neuroprotective Agents; Receptors, Purinergic P1; Stress, Physiological | 1995 |
23 other study(ies) available for adenosine and Nerve Degeneration
Article | Year |
---|---|
LPS-induced oxidative stress and inflammatory reaction in the rat striatum.
Topics: Adenosine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Glutamic Acid; Hydroxyl Radical; Inflammation; Injections, Intraperitoneal; Lipopolysaccharides; Microinjections; Nerve Degeneration; Neuroglia; Oxidative Stress | 2013 |
Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum.
Topics: Adenosine; Animals; Animals, Newborn; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Extracellular Fluid; Functional Laterality; Kynurenic Acid; Kynurenine; Mice; Mice, Knockout; Microdialysis; Nerve Degeneration; Norbornanes; Quinolinic Acid; Transaminases; Tritium | 2009 |
The purine nucleosides adenosine and guanosine delay axonal degeneration in vitro.
Topics: Adenosine; Animals; Axons; Cells, Cultured; Ganglia, Spinal; Guanosine; Mice; Nerve Degeneration; Purine Nucleosides; Wallerian Degeneration | 2009 |
Adenosine A1 receptor activation as a brake on the microglial response after experimental traumatic brain injury in mice.
Topics: Adenosine; Animals; Brain Injuries; Cell Line, Transformed; Cerebral Cortex; Disease Models, Animal; Female; Gliosis; Growth Inhibitors; Hippocampus; Male; Mice; Mice, Knockout; Microglia; Nerve Degeneration; Receptor, Adenosine A1; Thalamus | 2010 |
Differential neuroprotection by A(1) receptor activation and A(2A) receptor inhibition following pilocarpine-induced status epilepticus.
Topics: Adenosine; Analysis of Variance; Animals; Brain; Cell Count; Disease Models, Animal; Drug Interactions; Fluoresceins; Male; Nerve Degeneration; Neuroprotective Agents; Organic Chemicals; Phenylisopropyladenosine; Pilocarpine; Pyrimidines; Rats; Rats, Wistar; Reaction Time; Receptor, Adenosine A1; Receptor, Adenosine A2A; Status Epilepticus; Triazoles | 2011 |
Adenosine-mediated activation of Akt/protein kinase B in the rat hippocampus in vitro and in vivo.
Topics: Adenosine; Animals; Cell Death; Cerebrovascular Circulation; Hippocampus; Hypoxia-Ischemia, Brain; Immunohistochemistry; Male; Nerve Degeneration; Neurons; Organ Culture Techniques; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Subcellular Fractions; Synaptic Transmission; Theophylline; Up-Regulation | 2002 |
A1 adenosine receptor activation induces ventriculomegaly and white matter loss.
Topics: Adenosine; Animals; Animals, Newborn; Body Weight; Cell Count; Cerebral Cortex; Cerebral Ventricles; Drug Combinations; Drug Interactions; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Hippocampus; Microscopy, Electron; Myelin Basic Protein; Nerve Degeneration; Nerve Fibers, Myelinated; Neuroglia; Neurons; Presynaptic Terminals; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Telencephalon; Theophylline | 2002 |
Biochemical brain markers and purinergic parameters in rat CSF after seizure induced by pentylenetetrazol.
Topics: Adenosine; Adenosine Diphosphate; Animals; Antigens, CD; Apyrase; Biomarkers; Brain; Convulsants; Disease Models, Animal; Female; Guanosine; Guanosine Diphosphate; Hydrolysis; Inosine; Nerve Degeneration; Nerve Growth Factors; Nerve Tissue Proteins; Pentylenetetrazole; Phosphopyruvate Hydratase; Purines; Rats; Rats, Wistar; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Seizures; Time Factors; Up-Regulation | 2004 |
A mouse model of cerebral oligemia: relation to brain histopathology, cerebral blood flow, and energy state.
Topics: Adenosine; Adenosine Triphosphate; Animals; Biomarkers; Brain Ischemia; Carotid Stenosis; Cerebral Cortex; Cerebrovascular Circulation; Disease Models, Animal; Down-Regulation; Energy Metabolism; Female; Mice; Mice, Inbred DBA; Nerve Degeneration; Neurons; Oxidative Phosphorylation; Phosphocreatine; Up-Regulation | 2005 |
Purine nucleoside-mediated protection of chemical hypoxia-induced neuronal injuries involves p42/44 MAPK activation.
Topics: Adenosine; Animals; Cell Hypoxia; Cell Survival; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Guanosine; Hypoxia, Brain; Inosine; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nerve Degeneration; Nerve Growth Factor; Neuroprotective Agents; PC12 Cells; Purine Nucleosides; Rats; Rotenone; Uncoupling Agents | 2005 |
Increase of adenosine A1 receptor gene expression in cerebral ischemia of Wistar rats.
Topics: Adenosine; Animals; Brain Ischemia; Cerebral Cortex; Cerebral Infarction; Cerebrovascular Circulation; Cytoprotection; Disease Models, Animal; Gene Expression Regulation; Male; Nerve Degeneration; Rats; Rats, Wistar; Receptor, Adenosine A1; Reperfusion Injury; RNA, Messenger; Up-Regulation | 2005 |
Neuroprotective effects of hibernation-regulating substances against low-temperature-induced cell death in cultured hamster hippocampal neurons.
Topics: Adenosine; Analgesics, Opioid; Animals; Body Temperature; Cell Death; Cells, Cultured; Cricetinae; Dose-Response Relationship, Drug; Hibernation; Hippocampus; Histamine; Histamine H1 Antagonists; Hypothermia, Induced; Injections, Intraventricular; Narcotic Antagonists; Nerve Degeneration; Neurons; Neuroprotective Agents; Purinergic P1 Receptor Antagonists; Receptors, Opioid; Receptors, Purinergic P1; Thyrotropin-Releasing Hormone | 2006 |
Characterization and localization of adenosine receptors in rat spinal cord.
Topics: Adenosine; Animals; Autoradiography; Binding Sites; Kainic Acid; Male; Nerve Degeneration; Rats; Receptors, Cell Surface; Receptors, Purinergic; Spinal Cord; Tissue Distribution | 1984 |
Axonal transport and transcellular transfer of nucleosides and polyamines in intact and regenerating optic nerves of goldfish: speculation on the axonal regulation of periaxonal cell metabolism.
Topics: Adenosine; Animals; Axonal Transport; Axons; Biological Transport; Goldfish; Kinetics; Nerve Degeneration; Optic Nerve; Polyamines; Putrescine; Ribonucleotides; Spermidine; Uridine | 1982 |
Adenosinergic modulation of CA1 neuronal tolerance to glucose deprivation in organotypic hippocampal cultures.
Topics: Adenosine; Animals; Cell Survival; Glucose; Hippocampus; Hypoglycemia; Nerve Degeneration; Organ Culture Techniques; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Xanthines | 1994 |
Intraspinal injection of adenosine agonists protect against L-NAME induced neuronal loss in the rat.
Topics: Adenosine; Animals; Disease Models, Animal; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Injections, Spinal; Male; N-Methylaspartate; Nerve Degeneration; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Purinergic P1 Receptor Agonists; Purinergic P2 Receptor Agonists; Rats; Rats, Long-Evans; Spinal Cord | 1998 |
Regeneration across cold preserved peripheral nerve allografts.
Topics: Action Potentials; Adenosine; Allopurinol; Animals; Axons; Collagen; Cryopreservation; Feasibility Studies; Freezing; Glutathione; Graft Rejection; Immunosuppression Therapy; Insulin; Male; Microsurgery; Nerve Degeneration; Nerve Fibers; Nerve Fibers, Myelinated; Nerve Regeneration; Neural Conduction; Organ Preservation Solutions; Raffinose; Rats; Rats, Inbred Lew; Sciatic Nerve; Time Factors; Transplantation, Autologous; Transplantation, Homologous; Transplantation, Isogeneic; Walking | 1999 |
Endogenous adenosine protects CA1 neurons from kainic acid-induced neuronal cell loss in the rat hippocampus.
Topics: Adenosine; Animals; Apoptosis; Disease Models, Animal; Excitatory Amino Acid Agonists; Glial Fibrillary Acidic Protein; Hippocampus; Histocompatibility Antigens Class II; Injections, Intraventricular; Kainic Acid; Macrophage-1 Antigen; Male; Microtubule-Associated Proteins; Nerve Degeneration; Neuroglia; Neurons; Phosphorylation; Proto-Oncogene Proteins c-jun; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Theophylline | 1999 |
Sequential changes of [H]forskolin, [H]cyclohexyladenosine and [H]PN200-110 binding sites in the brain of 6-hydroxydopamine-lesioned rats.
Topics: Adenosine; Animals; Autoradiography; Binding Sites; Brain Chemistry; Calcium Channel Blockers; Calcium Channels; Colforsin; Corpus Striatum; Isradipine; Male; Medial Forebrain Bundle; Nerve Degeneration; Oxidopamine; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Substantia Nigra; Sympatholytics; Tritium | 2000 |
Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease.
Topics: Adenosine; Aged; Aged, 80 and over; Animals; Basal Ganglia; Corpus Striatum; Female; Guinea Pigs; Humans; Huntington Disease; Male; Middle Aged; Nerve Degeneration; Organ Specificity; Oxidopamine; Parkinson Disease; Quinolinic Acid; Quinolinic Acids; Receptors, Purinergic | 1991 |
Cholinergic and noradrenergic denervations decrease labelled purine release from electrically stimulated rat cortical slices.
Topics: Adenosine; Adrenergic Fibers; Animals; Basal Ganglia; Cerebral Cortex; Choline O-Acetyltransferase; Cholinergic Fibers; Electric Stimulation; Hypoxanthine; Hypoxanthines; Ibotenic Acid; Inosine; Male; Nerve Degeneration; Purines; Rats; Rats, Inbred Strains | 1989 |
Quinolinic acid neurotoxicity: protection by intracerebral phenylisopropyladenosine (PIA) and potentiation by hypotension.
Topics: Adenosine; Animals; Blood Pressure; Hippocampus; Hypotension; Male; Nerve Degeneration; Phenylisopropyladenosine; Pyridines; Quinolinic Acids; Rats; Rats, Inbred Strains; Trimethaphan | 1989 |
Biochemical studies on 5'-nucleotidase of Schwann cells in degenerated nerve.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Cats; Cell Membrane; Concanavalin A; Female; Male; Methylmannosides; Nerve Degeneration; Nucleotidases; Schwann Cells; Sciatic Nerve; Uridine Diphosphate | 1985 |